Industry: Chemical & Material
Published Date: 2025-01-13
Pages: 86 Pages
Report ld: 3500089
Request Sample
Customized Report
Poly(L-lactide-co-caprolactone) Market Size(US$)

CAGR 2025-2031
7.2%
Market Size,2031
USD 27.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
North American market for Poly(L-lactide-co-caprolactone) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Poly(L-lactide-co-caprolactone) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Poly(L-lactide-co-caprolactone) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Poly(L-lactide-co-caprolactone) include Evonik, BMG, KD Finechem, Nomisma Healthcare, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Poly(L-lactide-co-caprolactone), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Poly(L-lactide-co-caprolactone) by region & country, by Type, and by Application.
The Poly(L-lactide-co-caprolactone) market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poly(L-lactide-co-caprolactone).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Poly(L-lactide-co-caprolactone) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Poly(L-lactide-co-caprolactone) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Poly(L-lactide-co-caprolactone) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Poly(L-lactide-co-caprolactone) Product Introduction
1.2 Global Poly(L-lactide-co-caprolactone) Market Size Forecast
1.2.1 Global Poly(L-lactide-co-caprolactone) Sales Value (2020-2031)
1.2.2 Global Poly(L-lactide-co-caprolactone) Sales Volume (2020-2031)
1.2.3 Global Poly(L-lactide-co-caprolactone) Sales Price (2020-2031)
1.3 Poly(L-lactide-co-caprolactone) Market Trends & Drivers
1.3.1 Poly(L-lactide-co-caprolactone) Industry Trends
1.3.2 Poly(L-lactide-co-caprolactone) Market Drivers & Opportunity
1.3.3 Poly(L-lactide-co-caprolactone) Market Challenges
1.3.4 Poly(L-lactide-co-caprolactone) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Poly(L-lactide-co-caprolactone) Players Revenue Ranking (2024)
2.2 Global Poly(L-lactide-co-caprolactone) Revenue by Company (2020-2025)
2.3 Global Poly(L-lactide-co-caprolactone) Players Sales Volume Ranking (2024)
2.4 Global Poly(L-lactide-co-caprolactone) Sales Volume by Company Players (2020-2025)
2.5 Global Poly(L-lactide-co-caprolactone) Average Price by Company (2020-2025)
2.6 Key Manufacturers Poly(L-lactide-co-caprolactone) Manufacturing Base and Headquarters
2.7 Key Manufacturers Poly(L-lactide-co-caprolactone) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Poly(L-lactide-co-caprolactone)
2.9 Poly(L-lactide-co-caprolactone) Market Competitive Analysis
2.9.1 Poly(L-lactide-co-caprolactone) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Poly(L-lactide-co-caprolactone) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poly(L-lactide-co-caprolactone) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 LCL(75:25)
3.1.2 LCL(70:30)
3.1.3 LCL(50:50)
3.1.4 Others
3.2 Global Poly(L-lactide-co-caprolactone) Sales Value by Type
3.2.1 Global Poly(L-lactide-co-caprolactone) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Poly(L-lactide-co-caprolactone) Sales Value, by Type (2020-2031)
3.2.3 Global Poly(L-lactide-co-caprolactone) Sales Value, by Type (%) (2020-2031)
3.3 Global Poly(L-lactide-co-caprolactone) Sales Volume by Type
3.3.1 Global Poly(L-lactide-co-caprolactone) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Poly(L-lactide-co-caprolactone) Sales Volume, by Type (2020-2031)
3.3.3 Global Poly(L-lactide-co-caprolactone) Sales Volume, by Type (%) (2020-2031)
3.4 Global Poly(L-lactide-co-caprolactone) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Absorbable Suture
4.1.2 Drug Delivery
4.1.3 Tissue Engineering
4.1.4 Others
4.2 Global Poly(L-lactide-co-caprolactone) Sales Value by Application
4.2.1 Global Poly(L-lactide-co-caprolactone) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Poly(L-lactide-co-caprolactone) Sales Value, by Application (2020-2031)
4.2.3 Global Poly(L-lactide-co-caprolactone) Sales Value, by Application (%) (2020-2031)
4.3 Global Poly(L-lactide-co-caprolactone) Sales Volume by Application
4.3.1 Global Poly(L-lactide-co-caprolactone) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Poly(L-lactide-co-caprolactone) Sales Volume, by Application (2020-2031)
4.3.3 Global Poly(L-lactide-co-caprolactone) Sales Volume, by Application (%) (2020-2031)
4.4 Global Poly(L-lactide-co-caprolactone) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Poly(L-lactide-co-caprolactone) Sales Value by Region
5.1.1 Global Poly(L-lactide-co-caprolactone) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Poly(L-lactide-co-caprolactone) Sales Value by Region (2020-2025)
5.1.3 Global Poly(L-lactide-co-caprolactone) Sales Value by Region (2026-2031)
5.1.4 Global Poly(L-lactide-co-caprolactone) Sales Value by Region (%), (2020-2031)
5.2 Global Poly(L-lactide-co-caprolactone) Sales Volume by Region
5.2.1 Global Poly(L-lactide-co-caprolactone) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Poly(L-lactide-co-caprolactone) Sales Volume by Region (2020-2025)
5.2.3 Global Poly(L-lactide-co-caprolactone) Sales Volume by Region (2026-2031)
5.2.4 Global Poly(L-lactide-co-caprolactone) Sales Volume by Region (%), (2020-2031)
5.3 Global Poly(L-lactide-co-caprolactone) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
5.4.2 North America Poly(L-lactide-co-caprolactone) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
5.5.2 Europe Poly(L-lactide-co-caprolactone) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
5.6.2 Asia Pacific Poly(L-lactide-co-caprolactone) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
5.7.2 South America Poly(L-lactide-co-caprolactone) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
5.8.2 Middle East & Africa Poly(L-lactide-co-caprolactone) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Poly(L-lactide-co-caprolactone) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Poly(L-lactide-co-caprolactone) Sales Value
6.2.1 Key Countries/Regions Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Poly(L-lactide-co-caprolactone) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.3.2 United States Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.4.2 Europe Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.5.2 China Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.6.2 Japan Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.7.2 South Korea Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.8.2 Southeast Asia Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Poly(L-lactide-co-caprolactone) Sales Value, 2020-2031
6.9.2 India Poly(L-lactide-co-caprolactone) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Poly(L-lactide-co-caprolactone) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Evonik
7.1.1 Evonik Company Information
7.1.2 Evonik Introduction and Business Overview
7.1.3 Evonik Poly(L-lactide-co-caprolactone) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Evonik Poly(L-lactide-co-caprolactone) Product Offerings
7.1.5 Evonik Recent Development
7.2 BMG
7.2.1 BMG Company Information
7.2.2 BMG Introduction and Business Overview
7.2.3 BMG Poly(L-lactide-co-caprolactone) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 BMG Poly(L-lactide-co-caprolactone) Product Offerings
7.2.5 BMG Recent Development
7.3 KD Finechem
7.3.1 KD Finechem Company Information
7.3.2 KD Finechem Introduction and Business Overview
7.3.3 KD Finechem Poly(L-lactide-co-caprolactone) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 KD Finechem Poly(L-lactide-co-caprolactone) Product Offerings
7.3.5 KD Finechem Recent Development
7.4 Nomisma Healthcare
7.4.1 Nomisma Healthcare Company Information
7.4.2 Nomisma Healthcare Introduction and Business Overview
7.4.3 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Nomisma Healthcare Poly(L-lactide-co-caprolactone) Product Offerings
7.4.5 Nomisma Healthcare Recent Development
8 Industry Chain Analysis
8.1 Poly(L-lactide-co-caprolactone) Industrial Chain
8.2 Poly(L-lactide-co-caprolactone) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Poly(L-lactide-co-caprolactone) Sales Model
8.5.2 Sales Channel
8.5.3 Poly(L-lactide-co-caprolactone) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 18.14 million in 2025 and is projected to reach US$ 29.32 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
The global Poly(L-lactide-co-caprolactone) market was valued at US$ 18.14 million in 2025 and is anticipated to reach US$ 29.32 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 116
USD 2900.00
(Single User License)
The global Poly(L-lactide-co-caprolactone) market size was US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 70
USD 4250.00
(Single User License)
The global Poly(L-lactide-co-caprolactone) market is projected to grow from US$ 17 million in 2024 to US$ 27.5 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 111
USD 4900.00
(Single User License)
The global market for Poly(L-lactide-co-caprolactone) was valued at US$ 17 million in the year 2024 and is projected to reach a revised size of US$ 27.5 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published Date: 2025-01-13
Pages: 83
USD 2900.00
(Single User License)
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published Date: 2024-04-15
Pages: 70
USD 4900.00
(Single User License)
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published Date: 2024-01-17
Pages: 83
USD 2900.00
(Single User License)
The global market for Poly(L-lactide-co-caprolactone) was estimated to be worth US$ 18.14 million in 2025 and is projected to reach US$ 29.32 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 119
The global Poly(L-lactide-co-caprolactone) market was valued at US$ 18.14 million in 2025 and is anticipated to reach US$ 29.32 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-04-18
Pages: 116
The global Poly(L-lactide-co-caprolactone) market size was US$ 17 million in 2024 and is forecast to a readjusted size of US$ 27.5 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 70
The global Poly(L-lactide-co-caprolactone) market is projected to grow from US$ 17 million in 2024 to US$ 27.5 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 111
The global market for Poly(L-lactide-co-caprolactone) was valued at US$ 17 million in the year 2024 and is projected to reach a revised size of US$ 27.5 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-01-13
Pages: 83
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published: 2024-04-15
Pages: 70
Poly(L-lactide-co-caprolactone) have been widely applied in biomedicine. These polymers exhibit excellent mechanical properties, biocompatibility, and biodegradability and can be manufactured into various implantable devices.
Published: 2024-01-17
Pages: 83
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now